文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

创伤失血性休克患者中Akt1-GSK3β信号通路的改变

ALTERATION OF AKT1-GSK3Β SIGNALING PATHWAY IN TRAUMA HEMORRHAGIC SHOCK PATIENTS.
PubMed 文献 · Shock · 2022-10-11
一句话结论创伤失血性休克患者中pAkt1下调和pGSK3β上调与休克严重程度、免疫细胞凋亡、炎症及死亡率相关,Akt1-GSK3β通路可能成为治疗靶点。

创伤失血性休克(THS)是全球主要致死致残原因,约50%患者死亡与脓毒症相关或无关。本研究通过测量Akt1-GSK3β信号通路磷酸化水平,探讨其在THS中的作用。结果显示,THS中pAkt1下调和pGSK3β上调与休克严重程度、免疫细胞凋亡、糖代谢改变、炎症、细胞因子风暴、止血及酸中毒显著相关,并导致伴或不伴脓毒症的死亡。首次表明失调的pAkt1-GSK3β通路导致THS中相反的细胞命运,Akt激活可能成为提高生存率的潜在策略。

要点

  • THS患者中pAkt1下调和pGSK3β上调与休克严重程度显著相关。
  • pAkt1-GSK3β失调与免疫细胞凋亡、糖代谢改变、炎症、细胞因子风暴、止血及酸中毒相关。
  • 该信号通路改变导致伴或不伴脓毒症的死亡。
  • 首次显示pAkt1-GSK3β通路失调在THS中导致相反的细胞命运。
  • Akt激活可能成为提高THS后生存率的潜在策略。

适用人群与场景

  • 创伤失血性休克患者

研究设计与关键结果

  • 研究测量了THS患者Akt1-GSK3β信号通路的磷酸化水平,发现pAkt1下调和pGSK3β上调与休克严重程度、免疫细胞凋亡、糖代谢改变、炎症、细胞因子风暴、止血及酸中毒显著相关,并导致伴或不伴脓毒症的死亡。

证据类型、等级与局限

  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,pAkt1-GSK3β信号通路的阐明可能为THS治疗提供新的重要靶点。
  • 作者认为,Akt激活可能成为提高THS后生存率的潜在策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Trauma hemorrhagic shock (THS) is a major cause of death and disability worldwide. It is the leading cause of death with or without sepsis in approximately 50% of patients. In THS, there is an incidence of cellular apoptosis, which contributes majorly to cellular dysfunction, organ failure, and mortality. The Akt (protein kinase B) isoform, Akt1, and glycogen synthase kinase 3β (Akt1-GSK3β) signaling pathway controls cell survival and apoptosis. Deleterious consequences of alteration of this signaling system might lead to inflammation, cytokine storm, and other diseases. Hence, in the present study, we investigated the role of this signaling system by measuring the phosphorylation levels of Akt1-GSK3β. Here, we demonstrated that the downregulation of pAkt1 and upregulation of pGSK3β in THS were significantly associated with the severity of the shock, apoptosis of immune cells, altered glucose metabolism, inflammation, cytokine storm, hemostasis, and acidosis, causing mortality with or without sepsis. For the first time, this study shows that a dysregulated pAkt1-GSK3β pathway causes contrasting cell fates in THS, leading to trauma pathology. Hence, the delineation and the implications of this signaling system may provide a new important target for the treatment of THS. In addition, Akt activation may become a potential strategy for increasing the survival rate following THS.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Kotarkonda LK, Bharathala S, Sinha TP, et al. ALTERATION OF AKT1-GSK3Β SIGNALING PATHWAY IN TRAUMA HEMORRHAGIC SHOCK PATIENTS. Shock. 2022. PMID: 36548639. doi:10.1097/SHK.0000000000002012

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。